Small Molecule “Silmitasertib” Repurposed as Inhibitor of Transforming Growth Factor Beta 1 for the Development of Therapeutics for Oral Submucous Fibrosis

<div>Time evolution and stability of hydrogen bonds formed. (a) Hydrogen bonds between TGF-<i>β</i>1 and silmitasertib. (b) Hydrogen bonds paired within 0.35 nm between TGF-<i>β</i>1 and silmitasertib.</div>

BioMed Research International

fig3

Figure 3

Figure 3: Small Molecule “Silmitasertib” Repurposed as Inhibitor of Transforming Growth Factor Beta 1 for the Development of Therapeutics for Oral Submucous Fibrosis 

Figure 3 | Small Molecule “Silmitasertib” Repurposed as Inhibitor of Transforming Growth Factor Beta 1 for the Development of Therapeutics for Oral Submucous Fibrosis 